Whitley Aamodt, MD, MPH

faculty photo
Assistant Professor of Neurology at the Hospital of the University of Pennsylvania
Department: Neurology

Contact information
330 S. 9th Street
Philadelphia, PA 19107
Office: 215-829-6500
Education:
BS (Neuroscience)
College of William & Mary, Williamsburg, VA, 2009.
MPH
University of Texas School of Public Health, 2015.
MD
University of Texas School of Medicine at San Antonio, 2015.
MSCE
University of Pennsylvania , 2022.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Aamodt, W., Willis, A., & Farrar, J.: Trends in acute care utilization at the end of life in Parkinson’s disease. Poster presentation at the Parkinson Study Group 32nd Annual Meeting and 34th Annual Symposium June 2022.

Aamodt, W., Lyons-Warren, A., Pieper, K., & Strowd, R.: A formal mentored peer review program quantitatively improves the quality of peer review. 2022 American Academy of Neurology Annual Meeting April 2022 Notes: oral presentation.

Delgado-Garcia, G., Aamodt, W., Merino, J., & Strowd, R: The Neurology Resident & Fellow Section (RFS): Performance, Internationalization, and Recent Challenges 2022 American Academy of Neurology Annual Meeting April 2022 Notes: oral presentation.

Aamodt, W., Hamedani, A.: Vascular Dementia. Neuro-ophthalmology Virtual Education Library: NOVEL. Spencer S. Eccles Health Sciences Library, University of Utah, February 2022 Notes: Available at: https://collections.lib.utah.edu/details?id=1713256

Aamodt WW, Chen-Plotkin AS.: Reply to: "Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)" Mov Disord 37(2): 436-437, Feb 2022.

Aamodt, W., Dahodwala, N: Health Disparities in Parkinson’s Disease: Improving Care for America’s Most Vulnerable Populations White Paper for the Michael J. Fox Foundation 2022.

Aamodt, W., Dubroff, J., Cheng, G., Taylor, B., Wood, S., Duda, J., & Morley, J. : Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced parkinsonism. npj Parkinson's Disease 2022 Notes: In Press.

Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX, Trojanowski JQ, Shaw LM, Chen-Plotkin AS.: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease. Mov Disord 36(12): 2945-2950, Dec 2021.

Aamodt WW, Travers J, Thibault D, Willis AW.: Hospital Magnet Status Associates With Inpatient Safety in Parkinson Disease. J Neurosci Nurs 53(3): 116-122, Jun 2021.

Aamodt, W., Dubroff, J., Cheng, G., Taylor, B., Wood, S., Duda, J., & Morley, J: Clinical predictors of underlying neurodegeneration in drug-induced parkinsonism 2021 American Academy of Neurology Virtual Meeting April 2021 Notes: poster presentation.

back to top
Last updated: 08/23/2022
The Trustees of the University of Pennsylvania